Company attributes
Industry
Location
CEO
Pitchbook URL
Legal Name
PeriphaGen Inc.
Legal classification
Number of Employees (Ranges)
1 – 10
Full Address
PeriphaGen, Inc. 2403 Sidney Street Suite 255 Pittsburgh, PA 152030
CIK Number
Founded Date
2012
0Total Funding Amount (USD)
22,500,000
Latest Funding Round Date
April 2014
Latest Funding Type
Patents Assigned (Count)
1
Country
Other attributes
Company Operating Status
Active
Periphagen is a biopharmaceutical company founded in 2012 by Darren Wolfe, David Krisky and James Wechuck. It develops herpes simplex virus type I (HSV-1) as a gene therapy vector and focuses on the use of HSV-1 vectors for neurologic disease.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
